- The shares of the Ireland-based biotech Amarin Corporation ( NASDAQ: AMRN ) added ~12% on Tuesday to reach the highest level since May 2022 on above-average volume even as its largest shareholder Sarissa Capital Management seeks changes to the company’s board.
- Nearly 10M Amarin ( AMRN ) shares have changed hands, compared to the 65-day average of ~4.2M.
- The upsurge comes a day after the company said it sent a letter to investors “addressing the false and misleading statements made by Sarissa.”
- Amarin ( AMRN ) has also filed an investor presentation with the U.S. Securities and Exchange Commission urging shareholders to vote against Sarissa’s proposals at the upcoming General Meeting of Shareholders scheduled for Feb. 28.
For further details see:
Amarin hits nine-month high amid proxy battle with Sarissa